https://orcid.org/0000-0001-7469-4752
Citations (337)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (31)
Sreevidya S. Devi, Vandana Kardam, Kshatresh D. Dubey & Manish Dwivedi. (2023) Deciphering the immunogenic T-cell epitopes from spike protein of SARS-CoV-2 concerning the diverse population of India. Journal of Biomolecular Structure and Dynamics 41:7, pages 2713-2732.
Read now
Read now
Iqbal Pramukti, Carol Strong, I-Hua Chen, Cheng-Fang Yen, Ahmad Rifai, Kusman Ibrahim, Moses Glorino Rumambo Pandin, Hema Subramaniam, Mark D Griffiths, Chung-Ying Lin & Nai-Ying Ko. (2022) The Motors of COVID-19 Vaccination Acceptance Scale (MoVac-COVID19S): Measurement Invariant Evidence for Its Nine-Item Version in Taiwan, Indonesia, and Malaysia. Psychology Research and Behavior Management 15, pages 1617-1625.
Read now
Read now
Gabriel I. Nistor, Robert O. Dillman, Rockelle M. Robles, James L. Langford, Aleksandra J. Poole, Muchlis A. U. Sofro, Yetty M. Nency, Jonny Jonny, Martina L. Yana, Mahammad Karyana, Endang S. Lestari, Ria Triwardhani, Mujahidah Mujahidah, Retty K. Sari, Nur A. Soetojo, Djoko Wibisono, Daniel Tjen, Taruna Ikrar, Gregory Sarkissian, Haryono Winarta, Terawan A. Putranto & Hans S. Keirstead. (2022) A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Wenlong Zhu, Hao Zou, Ying Song, Lili Ren & Yingjie Xu. (2022) Understanding the impact process of vaccine adoption for COVID-19. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Chung-Ying Lin, Chia-Wei Fan, Daniel Kwasi Ahorsu, Yu Ching Lin, Hui-Ching Weng & Mark D. Griffiths. (2022) Associations between vaccination and quality of life among Taiwan general population: A comparison between COVID-19 vaccines and flu vaccines. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Debanjan Sen, Samhita Bhaumik, Pradip Debnath & Sudhan Debnath. (2022) Potentiality of Moringa oleifera against SARS-CoV-2: identified by a rational computer aided drug design method. Journal of Biomolecular Structure and Dynamics 40:16, pages 7517-7534.
Read now
Read now
Chavan Sakshi, A. Harikrishnan, Selvakumar Jayaraman, Ahana Roy Choudhury & V. Veena. (2022) Predictive medicinal metabolites from Momordica dioica against comorbidity related proteins of SARS-CoV-2 infections. Journal of Biomolecular Structure and Dynamics 40:11, pages 5175-5188.
Read now
Read now
Jairo Azócar-Gallardo, Alex Ojeda-Aravena, Jorge Carrizo Largo & Claudio Hernández-Mosqueira. (2022) Can the immunological system of the upper respiratory tract, improved by physical exercise, act as a first immunological barrier against SARS-CoV-2?. Expert Review of Anti-infective Therapy 20:7, pages 981-986.
Read now
Read now
Manoj Kumar Sarangi, Sasmita Padhi, Shrivardhan Dheeman, Santosh Kumar Karn, L. D. Patel, Dong Kee Yi & Sitansu Sekhar Nanda. (2022) Diagnosis, prevention, and treatment of coronavirus disease: a review. Expert Review of Anti-infective Therapy 20:2, pages 243-266.
Read now
Read now
Mustafa Durmuş & Erkan Durar. (2022) The relationship between spiritual well-being and fear of COVID-19 among Turkish elders. Journal of Religion, Spirituality & Aging 34:1, pages 3-16.
Read now
Read now
Wenlong Zhu, Hao Zou, Ying Song, Lili Ren & Yingjie Xu. (2021) Understanding the continuous vaccination of the COVID-19 vaccine: an empirical study from China. Human Vaccines & Immunotherapeutics 17:12, pages 4954-4963.
Read now
Read now
Wael Alturaiki, Ayman Mubarak, Abduallah Al Jurayyan & Maged Gomaa Hemida. (2021) The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2. Human Vaccines & Immunotherapeutics 17:10, pages 3297-3309.
Read now
Read now
Mohd. Iqbal Yatoo, Zeenat Hamid, Izhar Rather, Qurat Ul Ain Nazir, Riyaz Ahmed Bhat, Abrar Ul Haq, Suhail Nabi Magray, Zulfqar Haq, Ranjit Sah, Ruchi Tiwari, SenthilKumar Natesan, Muhammad Bilal, Harapan Harapan & Kuldeep Dhama. (2021) Immunotherapies and immunomodulatory approaches in clinical trials - a mini review. Human Vaccines & Immunotherapeutics 17:7, pages 1897-1909.
Read now
Read now
Idris Nasir Abdullahi, Anthony Uchenna Emeribe, Hafeez Aderinsayo Adekola, Sharafudeen Dahiru Abubakar, Amos Dangana, Halima Ali Shuwa, Sunday Theophilus Nwoba, Jelili Olaide Mustapha, Muyideen Titilope Haruna, Kafayat Adepeju Olowookere, Olawale Sunday Animasaun, Charles Egede Ugwu, Solomon Oloche Onoja, Abdullahi Sani Gadama, Musa Mohammed, Isa Muhammad Daneji, Dele Ohinoyi Amadu, Peter Elisha Ghamba, Nkechi Blessing Onukegbe, Muhammad Sagir Shehu, Chiladi Isomah, Adamu Babayo & Abdurrahman El-Fulaty Ahmad. (2021) Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges. Human Vaccines & Immunotherapeutics 17:3, pages 620-637.
Read now
Read now
Chiranjib Chakraborty, Manojit Bhattacharya, Bidyut Mallick, Ashish Ranjan Sharma, Sang-Soo Lee & Govindasamy Agoramoorthy. (2021) SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development. Expert Review of Clinical Pharmacology 14:2, pages 225-237.
Read now
Read now
Emrullah Korkmaz, Stephen C. Balmert, Cara Donahue Carey, Geza Erdos & Louis D. Falo$suffix/text()$suffix/text(). (2021) Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases. Expert Opinion on Drug Delivery 18:2, pages 151-167.
Read now
Read now
Maxwell A. Stefan, Yooli K. Light, Jennifer L. Schwedler, Peter R. McIlroy, Colleen M. Courtney, Edwin A. Saada, Christine E. Thatcher, Ashlee M. Phillips, Feliza A. Bourguet, Catherine M. Mageeney, Summer A. McCloy, Nicole M. Collette, Oscar A. Negrete, Joseph S. Schoeniger, Dina R. Weilhammer & Brooke Harmon. (2021) Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies. mAbs 13:1.
Read now
Read now
Nikolay Kalvatchev & Ivo Sirakov. (2021) Respiratory viruses crossing the species barrier and emergence of new human coronavirus infectious disease. Biotechnology & Biotechnological Equipment 35:1, pages 37-42.
Read now
Read now
Nandeeta Samad, Temitayo Eniola Sodunke, Hasan Al Banna, Ashmita Sapkota, Aneeka Nawar Fatema, Katia Iskandar, Dilshad Jahan, Timothy Craig Hardcastle, Tanzina Nusrat, Tajkera Sultana Chowdhury & Mainul Haque. (2020) Convalescent Plasma Therapy for Management of COVID-19: Perspectives and Deployment in the Current Global Pandemic. Risk Management and Healthcare Policy 13, pages 2707-2728.
Read now
Read now
Kuldeep Dhama, Senthilkumar Natesan, Mohd. Iqbal Yatoo, Shailesh Kumar Patel, Ruchi Tiwari, Shailendra K Saxena & Harapan Harapan. (2020) Plant-based vaccines and antibodies to combat COVID-19: current status and prospects. Human Vaccines & Immunotherapeutics 16:12, pages 2913-2920.
Read now
Read now
Rinku Sharma, Arivukarasu Palanisamy, Kuldeep Dhama, Gorakh Mal, Birbal Singh & Karam Pal Singh. (2020) Exploring the possible use of saponin adjuvants in COVID-19 vaccine. Human Vaccines & Immunotherapeutics 16:12, pages 2944-2953.
Read now
Read now
Tushar Yadav, Nishant Srivastava, Gourav Mishra, Kuldeep Dhama, Swatantra Kumar, Bipin Puri & Shailendra K Saxena. (2020) Recombinant vaccines for COVID-19. Human Vaccines & Immunotherapeutics 16:12, pages 2905-2912.
Read now
Read now
Yashpal Singh Malik, Mohd Ikram Ansari, Balasubramanian Ganesh, Shubhankar Sircar, Sudipta Bhat, Tripti Pande, OR Vinodhkumar, Prashant Kumar, Mohd Iqbal Yatoo, Ruchi Tiwari, Nadia Touil, Shailesh Kumar Patel, Mamta Pathak, Khan Sharun & Kuldeep Dhama. (2020) BCG vaccine: a hope to control COVID-19 pandemic amid crisis. Human Vaccines & Immunotherapeutics 16:12, pages 2954-2962.
Read now
Read now
Khan Sharun, Ruchi Tiwari, Shailesh Kumar Patel, Kumaragurubaran Karthik, Mohd Iqbal Yatoo, Yashpal S. Malik, Karam Pal Singh, Parmod Kumar Panwar, Harapan Harapan, Raj Kumar Singh & Kuldeep Dhama. (2020) Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: advances and prospects in the development of animal models for vaccine and therapeutic research. Human Vaccines & Immunotherapeutics 16:12, pages 3043-3054.
Read now
Read now
Kumaragurubaran Karthik, Tuticorin Maragatham Alagesan Senthilkumar, Shanmugasundaram Udhayavel & Gopal Dhinakar Raj. (2020) Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-19. Human Vaccines & Immunotherapeutics 16:12, pages 3055-3060.
Read now
Read now
Mohd. Iqbal Yatoo, Zeenat Hamid, Oveas Rafiq Parray, Aasim Habib Wani, Abrar Ul Haq, Archana Saxena, Shailesh Kumar Patel, Mamta Pathak, Ruchi Tiwari, Yashpal Singh Malik, Ranjit Sah, Ali A. Rabaan, Alfonso J. Rodriguez Morales & Kuldeep Dhama. (2020) COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Human Vaccines & Immunotherapeutics 16:12, pages 2891-2904.
Read now
Read now
Khaled Habas, Chioma Nganwuchu, Fanila Shahzad, Rajendran Gopalan, Mainul Haque, Sayeeda Rahman, Anwarul Azim Majumder & Talat Nasim. (2020) Resolution of coronavirus disease 2019 (COVID-19). Expert Review of Anti-infective Therapy 18:12, pages 1201-1211.
Read now
Read now
Wangxue Chen. (2020) Promise and challenges in the development of COVID-19 vaccines. Human Vaccines & Immunotherapeutics 16:11, pages 2604-2608.
Read now
Read now
Khan Sharun, Ruchi Tiwari, Mohd. Iqbal Yatoo, Shailesh Kumar Patel, Senthilkumar Natesan, Jaideep Dhama, Yashpal S. Malik, Harapan Harapan, Raj Kumar Singh & Kuldeep Dhama. (2020) Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects. Expert Opinion on Biological Therapy 20:9, pages 1033-1046.
Read now
Read now
V.H. Masand, V. Rastija, M.K. Patil, A. Gandhi & A. Chapolikar. (2020) Extending the identification of structural features responsible for anti-SARS-CoV activity of peptide-type compounds using QSAR modelling. SAR and QSAR in Environmental Research 31:9, pages 643-654.
Read now
Read now
Ruchi Tiwari, Kuldeep Dhama, Khan Sharun, Mohd. Iqbal Yatoo, Yashpal Singh Malik, Rajendra Singh, Izabela Michalak, Ranjit Sah, D. Katterine Bonilla-Aldana & Alfonso J Rodriguez-Morales. (2020) COVID-19: animals, veterinary and zoonotic links. Veterinary Quarterly 40:1, pages 169-182.
Read now
Read now
Articles from other publishers (306)
Anna Kryshchyshyn-Dylevych, Danylo Kaminskyy & Roman Lesyk. (2023) In‐vitro antiviral screening of some thiopyranothiazoles. Chemico-Biological Interactions 386, pages 110738.
Crossref
Crossref
Jiajie Chen, Yinghui Wang, Chengtie Wu, Yin Xiao & Yufang Zhu. (2023) A coronavirus-mimic mesoporous silica nanosystem enables efficient targeted delivery of siRNA for anti-SARS-CoV‐2. Applied Materials Today 35, pages 101952.
Crossref
Crossref
Mithun Rudrapal, Soumya Bhattacharya & Dipak Chetia. 2023. Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19. Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19
166
199
.
Rui Zhang, Xingxiang Duan, Ye Liu, Jia Xu, Abdullkhaleg Ali Ghaleb Al-bashari, Peng Ye, Qingsong Ye & Yan He. (2023) The Application of Mesenchymal Stem Cells in Future Vaccine Synthesis. Vaccines 11:11, pages 1631.
Crossref
Crossref
Ayse ELKOCA, Çağla YİĞİTBAŞ & Handan ÖZCAN. (2023) Self-Efficacy in Nurses Caring for Covid-19 PatientsCovid-19 Hastalarına Bakım Veren Hemşirelerde Öz Yeterlilik. Sakarya Üniversitesi Holistik Sağlık Dergisi 6:2, pages 289-302.
Crossref
Crossref
Nagisa Tokunoh, Shigeyuki Tamiya, Masato Watanabe, Toru Okamoto, Jessica Anindita, Hiroki Tanaka, Chikako Ono, Toshiro Hirai, Hidetaka Akita, Yoshiharu Matsuura & Yasuo Yoshioka. (2023) A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice. Frontiers in Immunology 14.
Crossref
Crossref
Tushar Saha, Shubhra Sinha, Rhodri Harfoot, Miguel E. Quiñones-Mateu & Shyamal C. Das. (2023) Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection. Pharmaceutics 15:9, pages 2229.
Crossref
Crossref
Omar Mohammed Younus, Arif Parmaksiz & Amer Abdalla Goreal. (2023) Comparison of Sequencing and Phylogenetic Analysis of SARS-CoV-2 Spike Proteins Extracted from Patients and Travelers in Duhok-Iraq. Jundishapur Journal of Microbiology 16:6.
Crossref
Crossref
Deepak Kumar Jha, Kumar Pranay, Samiksha, Amit Kumar & Niti Yashvardhini. (2023) The status of COVID-19 vaccines in India: A review. Vacunas (English Edition) 24:3, pages 218-247.
Crossref
Crossref
Deepak Kumar Jha, Kumar Pranay, Samiksha, Amit Kumar & Niti Yashvardhini. (2023) The status of COVID-19 vaccines in India: A review. Vacunas 24:3, pages 218-247.
Crossref
Crossref
Xuemei He, Cai He, Weiqi Hong, Jingyun Yang & Xiawei Wei. (2023) Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development. Medicinal Research Reviews 43:4, pages 932-971.
Crossref
Crossref
Tahmeena Khan, Alfred J. Lawrence, Amos Nascimento & Rohan Srivastava. 2023. COVID-19: Origin, Impact and Management (Part 2). COVID-19: Origin, Impact and Management (Part 2)
78
95
.
K. Gurushankar, S. Ch. Jeyaseelan, M. Grishina, I. Siswanto, R. Tiwari & N. N. T. Puspaningsih. (2023) Density Functional Theory, Molecular Dynamics, and AlteQ Studies of Baimantuoluoamide A and Baimantuoluoamide B to Identify Potential Inhibitors of Mpro Proteins: a Novel Target for the Treatment of SARS COVID-19. JETP Letters 117:10, pages 781-790.
Crossref
Crossref
Saganuwan Alhaji Saganuwan. (2023) Protection of SARS-CoV-2 trial vaccines in human is a function of the viral genomes. RPS Pharmacy and Pharmacology Reports 2:3.
Crossref
Crossref
Yiting Zhang, Setrice Patricia Clarke, Huanwu Wu, Wenli Li, Chang Zhou, Kang Lin, Jiawen Wang, Jinzhi Wang, Ying Liang, Xin Wang & Linding Wang. (2023) A comprehensive overview on the transmission, pathogenesis, diagnosis, treatment, and prevention of SARS‐CoV‐2. Journal of Medical Virology 95:5.
Crossref
Crossref
Irfan Gul, Amreena Hassan, Ehtishamul Haq, Syed Mudasir Ahmad, Riaz Ahmad Shah, Nazir Ahmad Ganai, Naveed Anjum Chikan, Mohamed Faizal Abdul-Careem & Nadeem Shabir. (2023) An Investigation of the Antiviral Potential of Phytocompounds against Avian Infectious Bronchitis Virus through Template-Based Molecular Docking and Molecular Dynamics Simulation Analysis. Viruses 15:4, pages 847.
Crossref
Crossref
Daysi Espín-Sánchez, María L. Ramos-Aristimbay, Andrés S. Sánchez-Vaca, Karen Jaramillo-Guapisaca, Carolina Vizueta-Rubio, Fernanda Chico-Terán, Liliana Cerda-Mejía & Mario D. García. (2023) Identificación de inhibidores de las enzimas RdRp y Mpro del virus SARS-CoV-2 mediante homología estructural. Bionatura 8:1, pages 1-11.
Crossref
Crossref
Shabina Ishtiaq Ahmed, Sehrish Jamil, Humaira Ismatullah, Rashid Hussain, Shabana Bibi, Mayeen Uddin Khandaker, Aisha Naveed, Abubakr M. Idris & Talha Bin Emran. (2023) A comprehensive perspective of traditional Arabic or Islamic medicinal plants as an adjuvant therapy against COVID-19. Saudi Journal of Biological Sciences 30:3, pages 103561.
Crossref
Crossref
Sameer KhasbageSayan Kumar DasAhmad NajmiBalakrishnan SadasivamSurjit Singh. (2023) Primary Prophylaxis of COVID-19: A Comprehensive Review of approved vaccines. Research Journal of Pharmacy and Technology, pages 917-923.
Crossref
Crossref
Xiang YuNa LiHui Wang. (2023) Observation on the R&D Effectiveness and Application of China's Novel Coronavirus Vaccine. Biotechnology Law Report 42:1, pages 25-32.
Crossref
Crossref
Shubhra Khare, Niharika, Ajey Singh, Imtiyaz Hussain, Narsingh Bahadur Singh & Subhash Singh. (2022) SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders. Applied Biochemistry and Biotechnology 195:2, pages 1541-1573.
Crossref
Crossref
Arup K. Kabi, Maynak Pal, Raghuram Gujjarappa, Chandi C. Malakar & Mithun Roy. (2022) Overview of Hydroxychloroquine and Remdesivir on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Journal of Heterocyclic Chemistry 60:2, pages 165-182.
Crossref
Crossref
Malik Suliman Mohamed, Ahmed Osman Mohamed, Rawaf Alenazy, Yusra Habib Khan, Mona Timan Idriss, Noura A. A. Alhudaib, Tilal Elsaman, Magdi Awadalla Mohamed, Eyman M. Eltayib & Tauqeer Hussain Mallhi. (2023) A First Report on Side-Effects of COVID-19 Vaccines among General Population in Sudan: A Cross-Sectional Analysis. Vaccines 11:2, pages 315.
Crossref
Crossref
Rajeev Mehla, Prasad Kokate, Sarika R. Bhosale, Vivek Vaidya, Shridhar Narayanan, Radha. K. Shandil, Mayas Singh, Gudepalya R. Rudramurthy, Chakenahalli N. Naveenkumar, Kumaraswamy Bharathkumar, Rob Coleman, Steffen Mueller, Rajeev M. Dhere & Leena R. Yeolekar. (2023) A Live Attenuated COVID-19 Candidate Vaccine for Children: Protection against SARS-CoV-2 Challenge in Hamsters. Vaccines 11:2, pages 255.
Crossref
Crossref
Marjorie C. Zambonino, Ernesto Mateo Quizhpe, Lynda Mouheb, Ashiqur Rahman, Spiros N. Agathos & Si Amar Dahoumane. (2023) Biogenic Selenium Nanoparticles in Biomedical Sciences: Properties, Current Trends, Novel Opportunities and Emerging Challenges in Theranostic Nanomedicine. Nanomaterials 13:3, pages 424.
Crossref
Crossref
Premkumar DinuAbirami, Sugan Panneerselvam, KSampath Mouleeswaran, Govindarao Balajee, K Premkumar, SrinivasMettu Reddy & Joy Varghese. (2023) T- and B-cell immune response to COVID vaccination in liver transplant recipients based on interferon-gamma release assay and serum antibody levels. Gastroenterology, Hepatology and Endoscopy Practice 3:4, pages 153.
Crossref
Crossref
Abd Alhadi Hasan & Imad AlJarrah. (2022) Knowledge, Attitudes and Practices of Undergraduate Nursing Towards Novel Corona Virus (COVID 19). Disaster Medicine and Public Health Preparedness 17.
Crossref
Crossref
Priyanka Sharma, Tushar Joshi, Shalini Mathpal, Sushma Tamta & Subhash Chandra. 2023. Omics approaches and technologies in COVID-19. Omics approaches and technologies in COVID-19
321
337
.
Maaz Waseem, Amina Basheer, Farha Anwer, Fatima Shahid, Tahreem Zaheer & Amjad Ali. 2023. Omics approaches and technologies in COVID-19. Omics approaches and technologies in COVID-19
23
39
.
Ralph M. Trüeb, Maria Fernanda Reis Gavazzoni Dias, Hudson Dutra Rezende, Remberto Mauricio de la Cruz Vargas Vilte & Ricardo Romiti. 2023. Hair in Infectious Disease. Hair in Infectious Disease
303
365
.
Yunes Panahi, Mostafa Ghanei, Morteza Rahimi, Abbas Samim, Amir Vahedian‐Azimi, Stephen L. Atkin & Amirhossein Sahebkar. (2022) Evaluation the efficacy and safety of N‐acetylcysteine inhalation spray in controlling the symptoms of patients with COVID‐19: An open‐label randomized controlled clinical trial. Journal of Medical Virology 95:1.
Crossref
Crossref
V. S. Ermakov, V. N. Kravchuk, O. Ya. Porembskaya, K. V. Kuznetsov, E. A. Knyazev, A. V. Belikov, T. V. Garpinchenko, I. B. Kazakova, K. E. Lobzhanidze, R. V. Deev & S. A. Sayganov. (2022) Coronary bypass surgery on the background of Covid-19. A clinical case. Hirurg (Surgeon):6, pages 31-44.
Crossref
Crossref
Wamankar Suchita, Sahu Tilotma, Shrivastava Saurabh, Kumar Abhishek, Sahu Sagar & Kumar Lokesh. (2022) Molecular Elucidation and Therapeutic Targeting for Combating
COVID-19: Current Scenario and Future Prospective. Current Molecular Medicine 22:10, pages 894-907.
Crossref
Crossref
Sudheesh K. Shukla, Santanu Patra, Trupti R. Das, Dharmesh Kumar, Anshuman Mishra & Ashutosh Tiwari. (2022) Progress in COVID research and developments during pandemic. VIEW 3:6.
Crossref
Crossref
Te-Kai Sun, Wen-Chin Huang, Yu-Wen Sun, Jeng-Shyan Deng, Liang-Hsuan Chien, Ya-Ni Chou, Wen-Ping Jiang, Jaung-Geng Lin & Guan-Jhong Huang. (2022) Schizophyllum commune Reduces Expression of the SARS-CoV-2 Receptors ACE2 and TMPRSS2. International Journal of Molecular Sciences 23:23, pages 14766.
Crossref
Crossref
Tomy Muringayil Joseph, Akshay Maniyeri Suresh, Debarshi Kar Mahapatra, Józef Haponiuk & Sabu Thomas. (2022) The Efficacious Benefit of 25-Hydroxy Vitamin D to Prevent COVID-19: An In-Silico Study Targeting SARS-CoV-2 Spike Protein. Nutrients 14:23, pages 4964.
Crossref
Crossref
Iffat Elbarazi, Mohamed Yacoub, Omar Ahmed Reyad, Marwa Shawky Abdou, Yasir Ahmed Mohammed Elhadi, Khalid A. Kheirallah, Bayan F. Ababneh, Bayan Abu Hamada, Haider M. El Saeh, Nancy Ali, Azhar T. Rahma, Mohamed Mostafa Tahoun & Ramy Mohamed Ghazy. (2022) Exploring enablers and barriers toward COVID-19 vaccine acceptance among Arabs: A qualitative study. International Journal of Disaster Risk Reduction 82, pages 103304.
Crossref
Crossref
Mohd Ahmar Rauf, Maryam Nisar, Hosam Abdelhady, Navnath Gavande & Arun K. Iyer. (2022) Nanomedicine approaches to reduce cytokine storms in severe infections. Drug Discovery Today 27:11, pages 103355.
Crossref
Crossref
M Harish, C V Ranjith & C Sethulekshmy Nair. (2022) Effectiveness of Quercetin and Its Derivatives Against SARS CoV2 -In silico Approach. Journal of Experimental Biology and Agricultural Sciences 10:5, pages 1003-1015.
Crossref
Crossref
Kiki Ferawati, Kongmeng Liew, Eiji Aramaki & Shoko Wakamiya. (2022) Monitoring Mentions of COVID-19 Vaccine Side Effects on Japanese and Indonesian Twitter: Infodemiological Study. JMIR Infodemiology 2:2, pages e39504.
Crossref
Crossref
Arni S.R. Srinivasa Rao & Steven G. Krantz. (2022) Mathematical analysis and topology of SARS-CoV-2, bonding with cells and unbonding. Journal of Mathematical Analysis and Applications 514:2, pages 125664.
Crossref
Crossref
Hong-Yu Liang, Yuyan Wu, Vicky Yau, Huan-Xin Yin, Scott Lowe, Rachel Bentley, Mubashir Ayaz Ahmed, Wenjing Zhao & Chenyu Sun. (2022) SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19. Vaccines 10:9, pages 1538.
Crossref
Crossref
Giuseppe Calcaterra, Pier Paolo Bassareo, Cesare De Gregorio, Francesco Barilla, Francesco Romeo & Jawahar L. Mehta. (2022) COVID-19 Vaccine-Induced Pro-thrombotic Immune Thrombocytopenia
(VIPIT): State of the Art. Current Cardiology Reviews 18:5.
Crossref
Crossref
Dechun Zhang & Ahmed Bux Jamali. (2022) China’s “Weaponized” Vaccine: Intertwining Between International and Domestic Politics. East Asia 39:3, pages 279-296.
Crossref
Crossref
Gheorghiță Jugulete, Daniela Pacurar, Mirela Luminița Pavelescu, Mihaela Safta, Elena Gheorghe, Bianca Borcoș, Carmen Pavelescu, Mihaela Oros & Mădălina Merișescu. (2022) Clinical and Evolutionary Features of SARS-CoV-2 Infection (COVID-19) in Children, a Romanian Perspective. Children 9:9, pages 1282.
Crossref
Crossref
Ana Junça Silva, Patrícia Neves & António Caetano. (2022) Procrastination is not only a “thief of time”, but also a thief of happiness: it buffers the beneficial effects of telework on well-being via daily micro-events of IT workers. International Journal of Manpower.
Crossref
Crossref
Tao Li, Hongqi Zhang, Yuxiang Wang, Yunjia Wang, Qile Gao, Mingxing Tang, Shaohua Liu, Gengming Zhang & Chaofeng Guo. (2022) Cervical Staphylococcus aureus Infection after Receiving the Third Dose of COVID-19 Vaccination: A Case Report. Vaccines 10:8, pages 1276.
Crossref
Crossref
Aashray K. Gupta, Joshua G. Kovoor, Christopher D. Ovenden & Hugh C. Cullen. (2022) Paradigm shift: Beyond the COVID‐19 era, is YouTube the future of education for CABG patients?. Journal of Cardiac Surgery 37:8, pages 2292-2296.
Crossref
Crossref
Tushar Saha, Miguel E. Quiñones-Mateu & Shyamal C. Das. (2022) Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices. International Journal of Pharmaceutics 624, pages 122042.
Crossref
Crossref
Esra Polat & Fatma Yekta Ürkmez. (2022) Comparison of hematological and biochemical parameters in COVID-19 pneumonia patients before and after convalescent plasma (CP) treatment. Journal of Surgery and Medicine 6:7, pages 684-688.
Crossref
Crossref
Tushar Saha, Shubhra Sinha, Rhodri Harfoot, Miguel E. Quiñones-Mateu & Shyamal C. Das. (2022) Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder. Pharmaceutics 14:7, pages 1432.
Crossref
Crossref
SINDHU SHANMUGAM, PRIYANKA VENUGOPAL, DAMAL KANDADAI SRIRAM & MELVIN GEORGE. (2022) EVALUATION OF ADENOVIRAL VECTOR-BASED VACCINES FOR PREVENTION OF COVID-19 – AN OVERVIEW. Asian Journal of Pharmaceutical and Clinical Research, pages 6-16.
Crossref
Crossref
Swarnali Das, Sovan Samanta, Jhimli Banerjee, Amitava Pal, Biplab Giri, Suvrendu Sankar Kar & Sandeep Kumar Dash. (2022) Is Omicron the end of pandemic or start of a new innings?. Travel Medicine and Infectious Disease 48, pages 102332.
Crossref
Crossref
Vidya Mave, Arsh Shaikh, Joy Merwin Monteiro, Prasad Bogam, Bhalchandra S. Pujari & Nikhil Gupte. (2022) Association of national and regional lockdowns with COVID-19 infection rates in Pune, India. Scientific Reports 12:1.
Crossref
Crossref
Jagan Mohan Rao Tingirikari & Anjaneyulu Musini. (2022) Bioactive Compounds from Plants and their Immune Potential against
Corona Virus. Current Nutrition & Food Science 18:5, pages 432-440.
Crossref
Crossref
John K. Ahiakpa, Nanma T. Cosmas, Felix E. Anyiam, Kingsley O. Enalume, Ibrahim Lawan, Ijuptil B. Gabriel, Chinonyelum L. Oforka, Hamze G. Dahir, Salisu T. Fausat, Maureen A. Nwobodo, Getrude P. Massawe, Adachukwu S. Obagha, Debra U. Okeh, Benjamin Karikari, Samuel T. Aderonke, Olushola M. Awoyemi, Idowu A. Aneyo & Funmilayo V. Doherty. (2022) COVID-19 vaccines uptake: Public knowledge, awareness, perception and acceptance among adult Africans. PLOS ONE 17:6, pages e0268230.
Crossref
Crossref
Jiaxing Liu, Ming Hao, Shulei Chen, Yang Yang, Jian Li, Qi Mei, Xin Bian & Kun Liu. (2022) Numerical evaluation of face masks for prevention of COVID-19 airborne transmission. Environmental Science and Pollution Research 29:29, pages 44939-44953.
Crossref
Crossref
Tayfun ACAR & Burcu UÇAR. (2022) Angiotensin(1-7)-Stearic Acid Conjugate: Synthesis and Characterization. Journal of the Turkish Chemical Society Section A: Chemistry 9:2, pages 331-338.
Crossref
Crossref
Seyed Reza Banihashemi, Ali Es-haghi, Mohammad Hossein Fallah Mehrabadi, Mojtaba Nofeli, Ali Rezaei Mokarram, Alireza Ranjbar, Mo Salman, Monireh Hajimoradi, Seyad Hossein Razaz, Maryam Taghdiri, Mohsen Bagheri, Maryam Dadar, Zuhair Mohammad Hassan, Mohammad Eslampanah, Zahra Salehi Najafabadi, Mohsen Lotfi, Akbar Khorasani & Fereidoon Rahmani. (2022) Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models. Frontiers in Immunology 13.
Crossref
Crossref
Jia Kong, Wenxin Li, Jinyao Hu, Shixuan Zhao, Tianli Yue, Zhonghong Li & Yinqiang Xia. (2022) The Safety of Cold-Chain Food in Post-COVID-19 Pandemic: Precaution and Quarantine. Foods 11:11, pages 1540.
Crossref
Crossref
Iman Al Hashmi, Atika Khalaf, Vidya Seshan, Hilal Alsabti, Omar Al Omari, Dalal Yehia, Mohammed Baqer & Jamal Al Khadhuri. (2021) Maternal and Neonatal Outcomes of Healthy Pregnant Women With COVID-19 Versus High-risk Pregnant Women: A Multi-Center Case-Control Comparison Study. Clinical Nursing Research 31:4, pages 702-712.
Crossref
Crossref
Aashray K. Gupta, Alasdair Leslie, Joseph N. Hewitt, Joshua G. Kovoor, Christopher D. Ovenden, Suzanne Edwards, Justin C. Y. Chan & Michael G. Worthington. (2022)
Cardiac surgery on patients with
COVID
‐19: a systematic review and
meta‐analysis
. ANZ Journal of Surgery 92:5, pages 1007-1014.
Crossref
Crossref
Manojit Bhattacharya, Ashish Ranjan Sharma, Pratik Ghosh, Prasanta Patra, Bidhan Chandra Patra, Sang-Soo Lee & Chiranjib Chakraborty. (2022) Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach. Molecular Biotechnology 64:5, pages 510-525.
Crossref
Crossref
Kavita SekhriSangeeta BhanwraRuchika NandhaSuruchi AdityaDeepak Bhasin. (2022) Journey of Chloroquine/ Hydroxychloroquine in the management of COVID-19. Research Journal of Pharmacology and Pharmacodynamics, pages 110-116.
Crossref
Crossref
Nourhan M. Abd El-Aziz, Ibrahim Khalifa, Amira M. G. Darwish, Ahmed N. Badr, Huda Aljumayi, El-Sayed Hafez & Mohamed G. Shehata. (2022) Docking Analysis of Some Bioactive Compounds from Traditional Plants against SARS-CoV-2 Target Proteins. Molecules 27:9, pages 2662.
Crossref
Crossref
Sunil Kumar & Mukesh Choudhary. (2022)
Structure-based design and synthesis of copper(
ii
) complexes as antivirus drug candidates targeting SARS CoV-2 and HIV
. New Journal of Chemistry 46:15, pages 7128-7143.
Crossref
Crossref
Halil Can KÜÇÜKYILDIZ, Salih Kürşat ŞİMŞEK, Burçak SÖYLEMEZ, Giray GÜNEŞ, Fatih KOÇ & Ünal ÖZÜM. (2022) Coronavirus-19 pandemic and its impact on elective neurosurgical operations. Journal of Surgery and Medicine 6:3, pages 282-284.
Crossref
Crossref
Usha Adiga, Sachidananda Adiga, Varashree Bolar Suryakanth & Desy Thayyil Menambath. (2022) Osteoarthritis, Corticosteroids and Role of CYP Genes in COVID-19 Patients: A Mini Review. Journal of Pure and Applied Microbiology 16:1, pages 18-25.
Crossref
Crossref
Ghadeer A.R.Y. Suaifan, Bayan A. Alkhawaja & Aya A.M. Mohammed. (2022) RNA Coronaviruses’ Outbreaks: Recent Progress on the SARS-CoV-2
Pandemic Diagnostic Tests, Vaccination and Therapeutics. Mini-Reviews in Medicinal Chemistry 22:4, pages 617-628.
Crossref
Crossref
Prasanta R Mohapatra & Baijayantimala Mishra. (2022) Upcoming SARS-CoV-2 vaccine: expectations and reality. Postgraduate Medical Journal 98:e2, pages e75-e76.
Crossref
Crossref
B. Pilmis, I. Elkaibi, G. Péan de Ponfilly, H. Daikha, A. Bouzid, A. Guihot, N. Castreau, P. Pradere, H. Ketatni, A. Mondragon, G. Hayem, J. Le Pavec, S. Laplanche & A. Le Monnier. (2022) Evolution of anti-SARS-CoV-2 immune response in a cohort of French healthcare workers followed for 7 months. Infectious Diseases Now 52:2, pages 68-74.
Crossref
Crossref
Muneer Jan, Mushary Alqahtani, Khaled A Amer, Basel Althubait, Abdulrahman Ali S Aldosari & Abdulrahman Abdullah M Al mudawi. (2022) COVID-19 and Vaccine Hesitancy: Individual Determinants Among Saudis in Asir Region. Cureus.
Crossref
Crossref
Sandeep Kumar & Yasha Hasija. (2022) Immunoinformatics Tools: A boon in vaccine Development Against Covid-19. Immunoinformatics Tools: A boon in vaccine Development Against Covid-19.
Mona Sadat Larijani, Amitis Ramezani, Mohammad Reza Aghasadeghi & Seyed Mehdi Sadat. (2022) A Flash on Cell Therapy Strategies in Clinical Trials against SARS-CoV-2. Coronaviruses 3:2.
Crossref
Crossref
Saba Hasan, Manish Dwivedi, Sutanu Mukhopadhyay & Nandini Gupta. (2022) Landscape Determinants of Infectivity and Insights into Vaccine Development
and Effectiveness - Novel Coronavirus. Letters in Drug Design & Discovery 20:2, pages 119-143.
Crossref
Crossref
Patrick Müller, Hannah Maus, Stefan Josef Hammerschmidt, Philip Maximilian Knaff, Volker Mailänder, Tanja Schirmeister & Christian Kersten. (2022) Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising
Therapeutic Strategy. Current Medicinal Chemistry 29:4, pages 635-665.
Crossref
Crossref
Kleyton Santos Medeiros, Ana Paula Ferreira Costa, Ayane Cristine Alves Sarmento, Cijara Leonice Freitas & Ana Katherine Gonçalves. (2022) Side effects of COVID-19 vaccines: a systematic review and meta-analysis protocol of randomised trials. BMJ Open 12:2, pages e050278.
Crossref
Crossref
Mahesha, A.H. Udaya Kumar, K.G. Vindya, K.J. Pampa, K.S. Rangappa & N.K. Lokanath. (2022) Structure-property relationship in thioxotriaza-spiro derivative: Crystal structure and molecular docking analysis against SARS-CoV-2 main protease. Journal of Molecular Structure 1250, pages 131746.
Crossref
Crossref
Ranjeet Kumar Rout, Sk Sarif Hassan, Sabha Sheikh, Saiyed Umer, Kshira Sagar Sahoo & Amir H. Gandomi. (2022) Feature-extraction and analysis based on spatial distribution of amino acids for SARS-CoV-2 Protein sequences. Computers in Biology and Medicine 141, pages 105024.
Crossref
Crossref
Sunitha Kodidela, Sandip Godse, Asit Kumar, Xuyen H. Nguyen, Alina Cernasev, Lina Zhou, Ajay Kumar Singh, Hari K. Bhat & Santosh Kumar. (2022) Nutraceuticals in HIV and COVID-19-Related Neurological Complications: Opportunity to Use Extracellular Vesicles as Drug Delivery Modality. Biology 11:2, pages 177.
Crossref
Crossref
Kame A. Galán-Huerta, Samantha Flores-Treviño, Daniel Salas-Treviño, Paola Bocanegra-Ibarias, Ana M. Rivas-Estilla, Eduardo Pérez-Alba, Sonia A. Lozano-Sepúlveda, Daniel Arellanos-Soto & Adrián Camacho-Ortiz. (2022) Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico. Viruses 14:1, pages 154.
Crossref
Crossref
Hao Shen, Nu Zhang, Yuqing Liu, Xuerong Yang, Yuanyuan He, Qi Li, Xiaoyan Shen, Yulian Zhu & Yong Yang. (2022) The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs. Frontiers in Pharmacology 12.
Crossref
Crossref
Radhakrishnan Aadhith & Parthiban Brindha Devi. (2022) Passive Immunotherapeutic Approaches for Treating Covid-19: A Comprehensive Review. International Journal Of Pharmaceutical Research And Allied Sciences 11:2, pages 52-61.
Crossref
Crossref
Moutoshi Chakraborty & SaurabKishore Munshi. (2022) The prospects of employing probiotics in combating COVID-19. Tzu Chi Medical Journal 34:2, pages 148.
Crossref
Crossref
NikunjaKumar Das, S Prasanna, Priyanka Pandit & VaibhavLaxmikant Dudhat. (2022) How much can we rely on a scrambled COVID-19 vaccine? It is not the only way out!. Medical Journal of Dr. D.Y. Patil Vidyapeeth 0:0, pages 0.
Crossref
Crossref
Hsin-Kuo Ko, Wen-Kuang Yu, Sheng-Wei Pan, Wei-Chih Chen, Kuang-Yao Yang, Yi-Tsung Lin, Fu-Der Wang, Muh-Hwa YangYuh-Min Chen. (2021) Consensus statement and recommendations on the treatment of COVID-19: 2021 update. Journal of the Chinese Medical Association 85:1, pages 5-17.
Crossref
Crossref
Behnam Hashemi, Firouzi-Amandi Akram, Halimeh Amirazad, Mehdi Dadashpour, Milad Sheervalilou, Davood Nasrabadi, Majid Ahmadi, Roghayeh Sheervalilou, Mahdieh Ameri Shah Reza, Farhood Ghazi & Leila Roshangar. (2022) Emerging importance of nanotechnology-based approaches to control the COVID-19 pandemic; focus on nanomedicine iterance in diagnosis and treatment of COVID-19 patients. Journal of Drug Delivery Science and Technology 67, pages 102967.
Crossref
Crossref
Alisha Merchant, Vidal H. Tania, Mahaly Baptiste, Hashimul Ehsan & Gen Kaneko. 2022. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection
559
582
.
Arpana Parihar, Shivani Malviya & Raju Khan. 2022. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection
357
378
.
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
271
299
.
Lihong Guo, Yanting Zhao & YangQuan Chen. 2022. Advances in Nonlinear Dynamics. Advances in Nonlinear Dynamics
3
12
.
Fan Yang, Qi Zhang, Zhongshang Yuan, Saisai Teng, Lizhen Cui, Fuzhong Xue & Leyi Wei. (2021) Signaling Potential Therapeutic Herbal Medicine Prescription for Treating COVID-19 by Collaborative Filtering. Frontiers in Pharmacology 12.
Crossref
Crossref
Kensaku Murano, Youjia Guo & Haruhiko Siomi. (2021) The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines. Biochemical Society Transactions 49:6, pages 2879-2890.
Crossref
Crossref
Sayantan Laha & Raghunath Chatterjee. (2021) Temporal variations in country-specific mutational profiles of SARS-CoV-2: effect on vaccine efficacy. Future Virology 16:12, pages 805-819.
Crossref
Crossref
Suleiman Aminu, Mohammed Auwal Ibrahim & Abdullahi Balarabe Sallau. (2021) Interaction of SARS-CoV-2 spike protein with angiotensin converting enzyme inhibitors and selected compounds from the chemical entities of biological interest. Beni-Suef University Journal of Basic and Applied Sciences 10:1.
Crossref
Crossref
Yuanyuan He, Xiaojie Bai, Tiantian Zhu, Jialin Huang & Hong Zhang. (2021) What can the neurological manifestations of COVID-19 tell us: a meta-analysis. Journal of Translational Medicine 19:1.
Crossref
Crossref
Elvan Üstün, Serpil Demir Düşünceli, Feyzullah Coşkun & İsmail Özdemir. (2021) Molybdenum Carbonyl Complexes with Benzimidazole Derivatives Against SARS-CoV-2 by Molecular Docking and DFT/TDDFT Methods. Journal of Computational Biophysics and Chemistry 20:08, pages 815-827.
Crossref
Crossref
Nahid Rehman & Anjana Pandey. (2022) An Overview of COVID-19 and Its Vaccines. Biology Bulletin Reviews 11:S1, pages 47-64.
Crossref
Crossref
Ernesto M. Martell, Melaine González-Garcia, Ludger Ständker & Anselmo J. Otero-González. (2021) Host defense peptides as immunomodulators: The other side of the coin. Peptides 146, pages 170644.
Crossref
Crossref
Forrest L. Baker, Kyle A. Smith, Tiffany M. Zúñiga, Helena Batatinha, Grace M. Niemiro, Charles R. Pedlar, Shane C. Burgess, Emmanuel Katsanis & Richard J. Simpson. (2021) Acute exercise increases immune responses to SARS CoV-2 in a previously infected man. Brain, Behavior, & Immunity - Health 18, pages 100343.
Crossref
Crossref
Ekta Shirbhate, Jaiprakash Pandey, Vijay K. Patel, Mehnaz Kamal, Talha Jawaid, Bapi Gorain, Prashant Kesharwani & Harish Rajak. (2021) Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention. Pharmacological Reports 73:6, pages 1539-1550.
Crossref
Crossref
Deepali Chittora, Bhanu Raj Meena, Shivangi Mittholiya & Kanika Sharma. (2021) Updates of COVID-19. Research on Biomedical Engineering 37:4, pages 835-848.
Crossref
Crossref
Abdulaziz Alhazmi, Edrous Alamer, Siddig Abdelwahab, Nizar Khamjan, Abdullah Hamami, Moayad Haddad, Majid Darraj, Anwar M. Hashem & Abdullah Algaissi. (2021) Community-Based Seroprevalence of SARS-CoV-2 Antibodies following the First Wave of the COVID-19 Pandemic in Jazan Province, Saudi Arabia. International Journal of Environmental Research and Public Health 18:23, pages 12451.
Crossref
Crossref
Chen Wang, Daniel M Konecki, David C Marciano, Harikumar Govindarajan, Amanda M Williams, Brigitta Wastuwidyaningtyas, Thomas Bourquard, Panagiotis Katsonis & Olivier Lichtarge. (2021) Identification of evolutionarily stable functional and immunogenic sites across the SARS-CoV-2 proteome and greater coronavirus family. Bioinformatics 37:22, pages 4033-4040.
Crossref
Crossref
Hongjun Chen, Leisheng Zhang, Wei Zhang, Lili Liu, Zhihua Dai, Miao Chen & Donghang Zhang. (2021) Blood Purification in Severe and Critical COVID-19 Patients: A Case Series of 5 Patients. Frontiers in Public Health 9.
Crossref
Crossref
Hui Liu, Wenxia Zhu, Yilin Wu, Caini Jiang, Lili Huo & Amany Belal. (2021) COVID-19 Pandemic Between Severity Facts and Prophylaxis. Natural Product Communications 16:11, pages 1934578X2110412.
Crossref
Crossref
SHIKA TAMTA, O R VINODHKUMAR, A KARTHIKEYAN, Z B DUBAL, SHARUN KHAN, ABDUL RAHMAN A SAIED, MANISH DHAWAN, KULDEEP DHAMA & Y S MALIK. (2021) Epidemiological profiling of SARS-CoV-2 with focus on one-health approaches in mitigating COVID-19 pandemic. The Indian Journal of Animal Sciences 91:10.
Crossref
Crossref
Bapanaiah Penugonda, Payal Kansara, Tikal Kansara & Arjun K Kini. (2021) COVID-19 Crisis and Precautions in Dental Practice: A Review Report. Journal of Oral Health and Community Dentistry 15:2, pages 78-83.
Crossref
Crossref
Prapti Parkhe & Subhash Verma. (2021) Evolution, Interspecies Transmission, and Zoonotic Significance of Animal Coronaviruses. Frontiers in Veterinary Science 8.
Crossref
Crossref
Melissa P. Lokugamage, Daryll Vanover, Jared Beyersdorf, Marine Z. C. Hatit, Laura Rotolo, Elisa Schrader Echeverri, Hannah E. Peck, Huanzhen Ni, Jeong-Kee Yoon, YongTae Kim, Philip J. Santangelo & James E. Dahlman. (2021) Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs. Nature Biomedical Engineering 5:9, pages 1059-1068.
Crossref
Crossref
Carole Pelissier, Joelane Paredes, Martine Moulin, Thierry Bitot, Eric Fakra & Luc Fontana. (2021) Telework and Psychological Health in Hospital Staff during the First Wave of the COVID-19 Epidemic in France. International Journal of Environmental Research and Public Health 18:19, pages 10433.
Crossref
Crossref
İbrahim Özlü, Zeynep Öztürk, Zeynep Karaman Özlü, Erdal Tekin & Ali Gür. (2021) The effects of progressive muscle relaxation exercises on the anxiety and sleep quality of patients with COVID‐19: A randomized controlled study. Perspectives in Psychiatric Care 57:4, pages 1791-1797.
Crossref
Crossref
Daisuke Kikuchi, Daiki Ariyoshi, Yugo Suzuki, Yorinari Ochiai, Hiroyuki Odagiri, Junnosuke Hayasaka, Masami Tanaka, Tetsuya Morishima, Keita Kimura, Hiroshi Ezawa, Risa Iwamoto, Yoshinori Matsuwaki & Shu Hoteya. (2021) Possibility of new shielding device for upper gastrointestinal endoscopy. Endoscopy International Open 09:10, pages E1536-E1541.
Crossref
Crossref
Eknath D. Ahire & Sanjay J Kshirsagar. (2021) Immune responses induced by different vaccine platforms against coronavirus disease-19. Exploration of Immunology, pages 243-257.
Crossref
Crossref
Simon N. Mbugua, Lydia W. Njenga, Ruth A. Odhiambo, Shem O. Wandiga & Martin O. Onani. (2021) COVID-19 and Cancer Therapy: Interrelationships and Management of Cancer Cases in the Era of COVID-19. Journal of Chemistry 2021, pages 1-10.
Crossref
Crossref
Mario A. Quiroz-Juárez, Armando Torres-Gómez, Irma Hoyo-Ulloa, Roberto de J. León-Montiel & Alfred B. U’Ren. (2021) Identification of high-risk COVID-19 patients using machine learning. PLOS ONE 16:9, pages e0257234.
Crossref
Crossref
Alireza Naderi Sohi, Jafar Kiani, Ehsan Arefian, Arezou Khosrojerdi, Zahra Fekrirad, Shokoofeh Ghaemi, Mohammad Kazem Zim, Arsalan Jalili, Nazila Bostanshirin & Masoud Soleimani. (2021) Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque. Vaccines 9:9, pages 1007.
Crossref
Crossref
Marvin Hanisch & Bastian Rake. (2021) Repurposing without purpose? Early innovation responses to the COVID‐19 crisis: Evidence from clinical trials. R&D Management 51:4, pages 393-409.
Crossref
Crossref
Krishna Rao Gurugubelli & Ballambattu Vishnu Bhat. (2020) Coronavirus Disease 2019 Infection among Children: Pathogenesis, Treatment, and Outcome. Journal of Pediatric Intensive Care 10:03, pages 167-173.
Crossref
Crossref
Akeberegn Gorems Ayele, Engidaw Fentahun Enyew & Zemene Demelash Kifle. (2021) Roles of existing drug and drug targets for COVID-19 management. Metabolism Open 11, pages 100103.
Crossref
Crossref
Pravas Kumar Baral, Jiang Yin & Michael N.G. James. (2021) Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2. International Journal of Biological Macromolecules 186, pages 490-500.
Crossref
Crossref
Richa Jain, Ankit Jain & Santosh kumar Verma. (2021) Prediction of Epitope based Peptides for Vaccine Development from Complete Proteome of Novel Corona Virus (SARS-COV-2) Using Immunoinformatics. International Journal of Peptide Research and Therapeutics 27:3, pages 1729-1740.
Crossref
Crossref
Abhishek Dubey, Garima Kotnala, Tuhin K. Mandal, Subash C. Sonkar, Vijay K. Singh, Sameer A. Guru, Aastha Bansal, Monica Irungbam, Farah Husain, Binita Goswami, Ravindra K. Kotnala, Sonal Saxena, Sudhir K. Sharma, Kirti N. Saxena, Chhemendra Sharma, Suresh Kumar, Dinesh K. Aswal, Vikas Manchanda & Bidhan C. Koner. (2021) Evidence of the presence of SARS‐CoV‐2 virus in atmospheric air and surfaces of a dedicated COVID hospital. Journal of Medical Virology 93:9, pages 5339-5349.
Crossref
Crossref
Stephanie Ishack & Shari R. Lipner. (2021) Bioinformatics and immunoinformatics to support COVID‐19 vaccine development. Journal of Medical Virology 93:9, pages 5209-5211.
Crossref
Crossref
İrem KÜÇÜKYILDIZ. (2021) Sexual Dysfunction in Women during COVID-19 pandemic: A Hospital-Based, Prospective, Cross-sectional Comparative Study. Cumhuriyet Medical Journal.
Crossref
Crossref
Sujan Chatterjee, Snehasis Mishra, Kaustav Dutta Chowdhury, Chandan Kumar Ghosh & Krishna Das Saha. (2021) Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view. Life Sciences 278, pages 119580.
Crossref
Crossref
Premjith Gathiram, Jagidesa Moodley & Olive P. Khaliq. (2021) Covid-19 pandemic: Perspectives on management. Journal of Reproductive Immunology 146, pages 103344.
Crossref
Crossref
Aruca Calderón-Cholbi, Joaquín Mateu-Mollá & Laura Lacomba-Trejo. (2021) Estrés, vinculaciones afectivas y personalidad: un estudio en familiares de personas afectadas por COVID-19. Clínica Contemporánea 12:2.
Crossref
Crossref
Yashpal S. Malik, Prashant Kumar, Mohd Ikram Ansari, Maged G. Hemida, Mohamed E. El Zowalaty, Ahmed S. Abdel-Moneim, Balasubramanian Ganesh, Sina Salajegheh, Senthilkumar Natesan, Shubhankar Sircar, Muhammad Safdar, O. R. Vinodhkumar, Phelipe M. Duarte, Shailesh K. Patel, Jörn Klein, Parastoo Rahimi & Kuldeep Dhama. (2021) SARS-CoV-2 Spike Protein Extrapolation for COVID Diagnosis and Vaccine Development. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Rahul Chatterjee, Mrinmoy Ghosh, Susrita Sahoo, Santwana Padhi, Namrata Misra, Visakha Raina, Mrutyunjay Suar & Young-Ok Son. (2021) Next-Generation Bioinformatics Approaches and Resources for Coronavirus Vaccine Discovery and Development—A Perspective Review. Vaccines 9:8, pages 812.
Crossref
Crossref
Ayan Kumar Ghosh, Halli Miller, Konstance Knox, Madhuchhanda Kundu, Kelly J. Henrickson & Ravit Arav-Boger. (2021) Inhibition of Human Coronaviruses by Antimalarial Peroxides. ACS Infectious Diseases 7:7, pages 1985-1995.
Crossref
Crossref
Subrata Deb, Anthony Allen Reeves, Robert Hopefl & Rebecca Bejusca. (2021) ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential. Pharmaceuticals 14:7, pages 655.
Crossref
Crossref
Ranjith Kumavath, Debmalya Barh, Bruno Silva Andrade, Madangchanok Imchen, Flavia Figueira Aburjaile, Athira Ch, Diego Lucas Neres Rodrigues, Sandeep Tiwari, Khalid J. Alzahrani, Aristóteles Góes-Neto, Marianna E. Weener, Preetam Ghosh & Vasco Azevedo. (2021) The Spike of SARS-CoV-2: Uniqueness and Applications. Frontiers in Immunology 12.
Crossref
Crossref
Uma Sankar Gorla, Koteswara Rao, Uma Sankar Kulandaivelu, Rajasekhar Reddy Alavala & Siva Prasad Panda. (2021) Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation. Combinatorial Chemistry & High Throughput Screening 24:6, pages 879-890.
Crossref
Crossref
Rakesh Kumar, Cut Meurah Yeni, Niken Asri Utami, Rupali Masand, Rajesh Kumar Asrani, Shailesh Kumar Patel, Akshay Kumar, Mohd. Iqbal Yatoo, Ruchi Tiwari, Senthilkumar Natesan, Kranti Suresh Vora, Firzan Nainu, Muhammad Bilal, Manish Dhawan, Talha Bin Emran, Tauseef Ahmad, Harapan Harapan & Kuldeep Dhama. (2021) SARS-CoV-2 infection during pregnancy and pregnancy-related conditions: Concerns, challenges, management and mitigation strategies–a narrative review. Journal of Infection and Public Health 14:7, pages 863-875.
Crossref
Crossref
Mahdi Ghorbani, Bernard R. Brooks & Jeffery B. Klauda. (2021) Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2. Biophysical Journal 120:14, pages 2902-2913.
Crossref
Crossref
Kuldeep Dhama, Shailesh Kumar Patel, Rakesh Kumar, Rupali Masand, Jigyasa Rana, Mohd. Iqbal Yatoo, Ruchi Tiwari, Khan Sharun, Ranjan K. Mohapatra, Senthilkumar Natesan, Manish Dhawan, Tauseef Ahmad, Talha Bin Emran, Yashpal Singh Malik & Harapan Harapan. (2021) The role of disinfectants and sanitizers during COVID-19 pandemic: advantages and deleterious effects on humans and the environment. Environmental Science and Pollution Research 28:26, pages 34211-34228.
Crossref
Crossref
Achal Mishra & Radhika Waghela. (2021) A Comparative Study of Approved Drugs for SARS-CoV-2 by Molecular Docking. Journal of Molecular Docking 1:1, pages 25-31.
Crossref
Crossref
İbrahim OZLU, Zeynep ÖZTÜRK, Zeynep KARAMAN ÖZLÜ & Beyzanur KIZILOĞLU. (2021) COVID-19 PANDEMİSİNİN ÇOCUKLARIN KORKU, KAYGI VE DEPRESYON DÜZEYLERİNE ETKİSİ. Journal of Anatolia Nursing and Health Sciences.
Crossref
Crossref
María Carrillo-Díaz, Laura Lacomba-Trejo, Martín Romero-Maroto & María José González-Olmo. (2021) Facial Self-Touching and the Propagation of COVID-19: The Role of Gloves in the Dental Practice. International Journal of Environmental Research and Public Health 18:13, pages 6983.
Crossref
Crossref
Ibrahim Aminu Shehu, Nura Mustapha Auwal, Muhammad Kabir Musa, Abubakar Mukhtar, Mashahudu Sha’arani Yusuf, Anees Ashir Yau, Murtala Muhammad, Yusuf Baba Dala, Salisu Abdullahi Sani, Mahmoud Seed Ahmad & Mojahidul Islam. (2021) Innovative Nanotechnology a Boon for Fight Against Pandemic COVID–19. Frontiers in Nanotechnology 3.
Crossref
Crossref
Mahendra Rai, Shital Bonde, Alka Yadav, Arpita Bhowmik, Sanjay Rathod, Pramod Ingle & Aniket Gade. (2021) Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations. Viruses 13:7, pages 1224.
Crossref
Crossref
Rambod Abiri, Hazandy Abdul-Hamid, Oksana Sytar, Ramin Abiri, Eduardo Bezerra de AlmeidaJr.Jr., Surender K. Sharma, Victor P. Bulgakov, Randolph R. J. Arroo & Sonia Malik. (2021) A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov. Molecules 26:13, pages 3868.
Crossref
Crossref
Elham Bidram, Yasaman Esmaeili, Abbas Amini, Rossella Sartorius, Franklin R. Tay, Laleh Shariati & Pooyan Makvandi. (2021) Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside. ACS Biomaterials Science & Engineering 7:6, pages 2150-2176.
Crossref
Crossref
Shammya Afroze, Md Sumon Reza, Quentin Cheok, Shafi Noor Islam, Abdalla M. Abdalla, Juntakan Taweekun, Abul K. Azad, Nima Khalilpoor & Alibek Issakhov. (2021) Advanced Applications of Fuel Cells during the COVID-19 Pandemic. International Journal of Chemical Engineering 2021, pages 1-9.
Crossref
Crossref
Andrés Felipe Cuspoca, Laura Lorena Díaz, Alvaro Fernando Acosta, Marcela Katherine Peñaloza, Yardany Rafael Méndez, Diana Carolina Clavijo & Juvenal Yosa Reyes. (2021) An Immunoinformatics Approach for SARS-CoV-2 in Latam Populations and Multi-Epitope Vaccine Candidate Directed towards the World’s Population. Vaccines 9:6, pages 581.
Crossref
Crossref
Marzuq A. Ungogo, Mustapha Mohammed, Bala N. Umar, Auwal A. Bala & Garba M. Khalid. (2021) Review of pharmacologic and immunologic agents in the management of COVID-19. Biosafety and Health 3:3, pages 148-155.
Crossref
Crossref
Lili Ren, Guohui Fan, Wenjuan Wu, Li Guo, Yeming Wang, Xia Li, Conghui Wang, Xiaoying Gu, Caihong Li, Ying Wang, Geng Wang, Fei Zhou, Zhibo Liu, Qing Ge, Yi Zhang, Hui Li, Lulu Zhang, Jiuyang Xu, Chen Wang, Jianwei Wang & Bin Cao. (2021) Antibody Responses and Clinical Outcomes in Adults Hospitalized With Severe Coronavirus Disease 2019 (COVID-19): A Post hoc Analysis of LOTUS China Trial. Clinical Infectious Diseases 72:10, pages e545-e551.
Crossref
Crossref
Tianhua Zhai, Fangyuan Zhang, Shozeb Haider, Daniel Kraut & Zuyi Huang. (2021) An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Muhammad Taher, Noratika Tik & Deny Susanti. (2021) Drugs intervention study in COVID-19 management. Drug Metabolism and Drug Interactions 36:2, pages 87-98.
Crossref
Crossref
Ali Pormohammad, Mohammad Zarei, Saied Ghorbani, Mehdi Mohammadi, Mohammad Hossein Razizadeh, Diana L. Turner & Raymond J. Turner. (2021) Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Vaccines 9:5, pages 467.
Crossref
Crossref
Ekta Shirbhate, Preeti Patel, Vijay K Patel, Ravichandran Veerasamy, Prabodh C Sharma, Barij N Sinha & Harish Rajak. (2021) Synthetic and Semi-synthetic Drugs as a Promising Therapeutic Option for the Treatment of COVID-19. Mini-Reviews in Medicinal Chemistry 21:8, pages 1004-1016.
Crossref
Crossref
Jubeda Begum, Nasir Akbar Mir, Kapil Dev, Bidyarani Buyamayum, Mohd Yaqoob Wani & Meesam Raza. (2020) Challenges and prospects of COVID‐19 vaccine development based on the progress made in SARS and MERS vaccine development. Transboundary and Emerging Diseases 68:3, pages 1111-1124.
Crossref
Crossref
G. Troiano & A. Nardi. (2021) Vaccine hesitancy in the era of COVID-19. Public Health 194, pages 245-251.
Crossref
Crossref
Mai H.S. Mohammad. (2021) Immune response scenario and vaccine development for SARS-CoV-2 infection. International Immunopharmacology 94, pages 107439.
Crossref
Crossref
Brilliant N. Marak, Jayanta Dowarah, Laldingluaia Khiangte & Ved Prakash Singh. (2020)
Step toward repurposing drug discovery for
COVID
‐19 therapeutics through in silico approach
. Drug Development Research 82:3, pages 374-392.
Crossref
Crossref
Bestegül ÇORUH AKYOL, Muhammed Zübeyr ÜÇÜNCÜ & Gökmen ÖZCEYLAN. (2021) The Effect of the Coronavirus Outbreak on Childhood Vaccinations Made in Family Health Centers in TurkeyKoronavirüs Salgınının Türkiye'deki Aile Sağlığı Merkezlerinde Yapılan Çocukluk Aşılarına Etkisi. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi:13, pages 42-55.
Crossref
Crossref
A.A. Dawood, M.A.A. Altobje & Z.T. Al-Rrassam. (2021) Molecular Docking of SARS-CoV-2 Nucleocapsid Protein with Angiotensin-Converting Enzyme II. Mikrobiolohichnyi Zhurnal 83:2, pages 82-92.
Crossref
Crossref
Rajashri Bezbaruah, Pobitra Borah, Bibhuti Bhushan Kakoti, Nizar A. Al-Shar’I, Balakumar Chandrasekaran, Da’san M. M. Jaradat, Munir A. Al-Zeer & Saeid Abu-Romman. (2021) Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Mohamed Reda Aouad, Daoud J. O. Khan, Musa A. Said, Nadia S. Al‐Kaff, Nadjet Rezki, Adeeb A. Ali, Nahla Bouqellah & Mohamed Hagar. (2021) Novel 1,2,3‐Triazole Derivatives as Potential Inhibitors against Covid‐19 Main Protease: Synthesis, Characterization, Molecular Docking and DFT Studies. ChemistrySelect 6:14, pages 3468-3486.
Crossref
Crossref
Neeraj Kumar, Nikita Admane, Anchala Kumari, Damini Sood, Sonam Grover, Vijay Kumar Prajapati, Ramesh Chandra & Abhinav Grover. (2021) Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework. Scientific Reports 11:1.
Crossref
Crossref
Muhammad Taher, Noratika Tik & Deny Susanti. (2021) Drugs intervention study in COVID-19 management. Drug Metabolism and Personalized Therapy 0:0.
Crossref
Crossref
Rohini S. Kharwade & Sachin M. More. (2021) Coordinated Roadmap to Grip Pandemic COVID-19. Coronaviruses 2:4, pages 468-480.
Crossref
Crossref
Namra Mubarak, Samyia Safdar, Shazia Faiz, Jabran Khan & Mastura Jaafar. (2020) Impact of public health education on undue fear of COVID‐19 among nurses: The mediating role of psychological capital. International Journal of Mental Health Nursing 30:2, pages 544-552.
Crossref
Crossref
Subhrajit Mukherjee, Soumendu Boral, Hammad Siddiqi, Asmita Mishra & Bhim Charan Meikap. (2021) Present cum future of SARS-CoV-2 virus and its associated control of virus-laden air pollutants leading to potential environmental threat – A global review. Journal of Environmental Chemical Engineering 9:2, pages 104973.
Crossref
Crossref
Sami ULLAH, Abdullah Ghodran AL-SEHEMI, Jiří Jaromír KLEMEŠ, Sanam SAQIB, Sahibzada Muhammad Azib GONDAL, Sidra SAQIB, Akasha ARSHAD, Hira SAQIB, Ahmad MUKHTAR, Muhammad IBRAHIM, Saira ASIF & Awais BOKHARI. (2021) A Review of the Progress of COVID-19 Vaccine DevelopmentCOVID-19 Aşısı Geliştirme Süreci Üzerine Bir Değerlendirme. Düzce Tıp Fakültesi Dergisi 23:Special Issue, pages 1-23.
Crossref
Crossref
Giovanni Mazzocco, Iga Niemiec, Alexander Myronov, Piotr Skoczylas, Jan Kaczmarczyk, Anna Sanecka-Duin, Katarzyna Gruba, Paulina Król, Michał Drwal, Marian Szczepanik, Krzysztof Pyrc & Piotr Stȩpniak. (2021) AI Aided Design of Epitope-Based Vaccine for the Induction of Cellular Immune Responses Against SARS-CoV-2. Frontiers in Genetics 12.
Crossref
Crossref
Long Liu, Feng Zeng, Jingjing Rao, Shengren Yuan, Manshan Ji, Xu Lei, Xiao Xiao, Zhijun Li, Xiaohua Li, Weixing Du, Yanqing Liu, Huabing Tan, Junmin Li, Jianyong Zhu, Jing Yang & Zhixin Liu. (2021) Comparison of Clinical Features and Outcomes of Medically Attended COVID-19 and Influenza Patients in a Defined Population in the 2020 Respiratory Virus Season. Frontiers in Public Health 9.
Crossref
Crossref
Arumugam Vijaya Anand, Balasubramanian Balamuralikrishnan, Mohandass Kaviya, Kathirvel Bharathi, Aluru Parithathvi, Meyyazhagan Arun, Nachiappan Senthilkumar, Shanmugam Velayuthaprabhu, Muthukrishnan Saradhadevi, Naif Abdullah Al-Dhabi, Mariadhas Valan Arasu, Mohammad Iqbal Yatoo, Ruchi Tiwari & Kuldeep Dhama. (2021) Medicinal Plants, Phytochemicals, and Herbs to Combat Viral Pathogens Including SARS-CoV-2. Molecules 26:6, pages 1775.
Crossref
Crossref
Displaying 200 of 337 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list